{"title":"SARS-CoV-2 and Microbiota","authors":"S. Schippa, F. Pantanella","doi":"10.4172/2329-8901.1000217","DOIUrl":null,"url":null,"abstract":"This letter exposes some of the many reasons why microbiotamodulation in patients with COVID-19 disease and more ingeneral, in all people at greatest risk of contracting SARS-CoV2virus infections, should be taken into consideration.","PeriodicalId":16865,"journal":{"name":"Journal of Probiotics & Health","volume":"83 1","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Probiotics & Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2329-8901.1000217","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This letter exposes some of the many reasons why microbiotamodulation in patients with COVID-19 disease and more ingeneral, in all people at greatest risk of contracting SARS-CoV2virus infections, should be taken into consideration.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
